Thermo Fisher Scientific Inc. Share Price Buenos Aires S.E.

Equities

TMOD

ARBCOM4601F7

Advanced Medical Equipment & Technology

End-of-day quote Buenos Aires S.E. 23:00:00 13/04/2023 BST 5-day change 1st Jan Change
27 USD -.--% Intraday chart for Thermo Fisher Scientific Inc. -.--% -.--%
Sales 2024 * 43.01B 3,392B Sales 2025 * 46.08B 3,634B Capitalization 227B 17,908B
Net income 2024 * 6.11B 482B Net income 2025 * 7B 552B EV / Sales 2024 * 5.84 x
Net Debt 2024 * 23.99B 1,892B Net Debt 2025 * 19.18B 1,513B EV / Sales 2025 * 5.34 x
P/E ratio 2024 *
37.6 x
P/E ratio 2025 *
32 x
Employees 122,000
Yield 2024 *
0.25%
Yield 2025 *
0.27%
Free-Float 86.04%
More Fundamentals * Assessed data
Dynamic Chart
3 years
27.00
Extreme 27
27.00
5 years
27.00
Extreme 27
27.00
10 years
27.00
Extreme 27
27.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 31/10/01
Director of Finance/CFO 57 31/05/01
Chief Tech/Sci/R&D Officer - 31/12/18
Members of the board TitleAgeSince
Chief Executive Officer 56 31/10/01
Director/Board Member 67 29/03/12
Director/Board Member 62 28/02/22
More insiders
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
594.8 USD
Average target price
625.5 USD
Spread / Average Target
+5.16%
Consensus